Image Source: The Financial Express
India is exploring fresh opportunities in Mexico’s pharmaceutical sector, following a strategic discussion between Prime Minister Narendra Modi and Mexican President Claudia Sheinbaum during the G7 Summit in Canada. The two leaders agreed to deepen collaboration across sectors, with pharmaceuticals emerging as a key focus area.
Key Highlights:
-
Pharma Potential: India is eyeing Mexico’s growing demand for affordable, highquality generic drugs and vaccines
-
Supply Chain Advantage: Mexico’s nearshoring drive offers Indian pharma firms a route to coproduce and supply locally
-
Wider Collaboration: Talks also covered AI, semiconductors, and critical minerals
-
Political Backing: Both nations reaffirmed alignment on Global South priorities, wellness, and digital innovation
Mexico’s healthcare sector is actively looking to diversify suppliers and reduce dependency on existing trade routes, making India’s pharma strengths in generics and biopharma especially attractive. Joint ventures, tech transfer, and regulatory cooperation are now on the table.
President Sheinbaum praised India’s progress in digital public goods and healthcare delivery, while Prime Minister Modi highlighted the scope for more peopletopeople and institutional partnerships. The discussion also marks a shift in India’s efforts to diversify global markets and form new bilateral supply chains.
With both sides on the same page, India’s pharma move into Mexico could lead to deeper trade and diplomatic traction in Latin America.
Source: PM India, Indian Defence Research Wing, ABP Live
Advertisement
Advertisement